These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32269263)

  • 21. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
    Dillon CP; Balachandran S
    Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral Suppression of RIPK1-Mediated Signaling.
    Udawatte DJ; Rothman AL
    mBio; 2021 Aug; 12(4):e0172321. PubMed ID: 34372694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.
    Delanghe T; Dondelinger Y; Bertrand MJM
    Trends Cell Biol; 2020 Mar; 30(3):189-200. PubMed ID: 31959328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.
    Delanghe T; Huyghe J; Lee S; Priem D; Van Coillie S; Gilbert B; Choi SM; Vandenabeele P; Degterev A; Cuny GD; Dondelinger Y; Bertrand MJM
    Cell Death Dis; 2021 Jul; 12(7):699. PubMed ID: 34262020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The death-inducing activity of RIPK1 is regulated by the pH environment.
    Moriwaki K; Balaji S; Ka-Ming Chan F
    Sci Signal; 2020 May; 13(631):. PubMed ID: 32398349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Autophagy-Initiating Kinase ULK1 Controls RIPK1-Mediated Cell Death.
    Wu W; Wang X; Berleth N; Deitersen J; Wallot-Hieke N; Böhler P; Schlütermann D; Stuhldreier F; Cox J; Schmitz K; Seggewiß S; Peter C; Kasof G; Stefanski A; Stühler K; Tschapek A; Gödecke A; Stork B
    Cell Rep; 2020 Apr; 31(3):107547. PubMed ID: 32320653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting RIPK1-driven neuroinflammation and neuronal apoptosis mitigates brain injury following experimental subarachnoid hemorrhage.
    Wu Y; Xu Y; Sun J; Dai K; Wang Z; Zhang J
    Exp Neurol; 2024 Apr; 374():114705. PubMed ID: 38290652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E3 Ubiquitin-Protein Ligase RNF4 Promotes TNF-α-Induced Cell Death Triggered by RIPK1.
    Shimada T; Kudoh Y; Noguchi T; Kagi T; Suzuki M; Tsuchida M; Komatsu H; Takahashi M; Hirata Y; Matsuzawa A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting RIPK1 kinase for modulating inflammation in human diseases.
    Li W; Yuan J
    Front Immunol; 2023; 14():1159743. PubMed ID: 36969188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development.
    Zhang X; Dowling JP; Zhang J
    Cell Death Dis; 2019 Mar; 10(3):245. PubMed ID: 30867408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
    Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
    Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis.
    Filliol A; Piquet-Pellorce C; Raguénès-Nicol C; Dion S; Farooq M; Lucas-Clerc C; Vandenabeele P; Bertrand MJM; Le Seyec J; Samson M
    J Hepatol; 2017 Jun; 66(6):1205-1213. PubMed ID: 28088582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
    Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
    Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of RIPK1 kinase does not affect diabetes development: β-Cells survive RIPK1 activation.
    Takiishi T; Xiao P; Franchimont M; Gilglioni EH; Arroba EN; Gurzov EN; Bertrand MJ; Cardozo AK
    Mol Metab; 2023 Mar; 69():101681. PubMed ID: 36707047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring RIPK1 Phosphorylation in the TNFR1 Signaling Complex.
    Priem D; Dondelinger Y; Bertrand MJM
    Methods Mol Biol; 2018; 1857():171-179. PubMed ID: 30136241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities.
    Cao M; Chen F; Xie N; Cao MY; Chen P; Lou Q; Zhao Y; He C; Zhang S; Song X; Sun Y; Zhu W; Mou L; Luan S; Gao H
    Cell Death Dis; 2018 Nov; 9(12):1140. PubMed ID: 30442927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promyelocytic leukemia protein targets MK2 to promote cytotoxicity.
    Chen IT; Chen HC; Lo YH; Lai PY; Hsieh FY; Wu YH; Shih HM; Lai MZ
    EMBO Rep; 2021 Dec; 22(12):e52254. PubMed ID: 34633746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.